Differences in disease expression between primary ciliary dyskinesia and cystic fibrosis with and without pancreatic insufficiency

Chest

Volumn 145, Issue 4, 2014, Pages 738-744

  Cohen Cymberknoh, Malena ^a   Simanovsky, Natalia ^a   Hiller, Nurith ^a   Gileles Hillel, Alex ^a   Shoseyov, David ^a   Kerem, Eitan ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BODY MASS; CHILD; CILIARY DYSKINESIA; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE EXPRESSION; DISEASE SEVERITY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; GENERAL ASPECTS OF DISEASE; HAEMOPHILUS INFLUENZAE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG INJURY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MUCOCILIARY CLEARANCE; NUTRITIONAL STATUS; PANCREAS INSUFFICIENCY; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SCHOOL CHILD; TREND STUDY;

ADOLESCENT; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; EXOCRINE PANCREATIC INSUFFICIENCY; FEMALE; HUMANS; KARTAGENER SYNDROME; MALE;

EID: 84898749254     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-1162     Document Type: Article

References (36)

1. Knowles MR, Boucher RC. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest. 2002; 109 (5): 571-577 .
2. Bush A, Cole P, Hariri M, et al. Primary ciliary dyskinesia: diagnosis and standards of care. Eur Respir J. 1998; 12(4): 982- 988.
3. Leigh MW, Pittman JE, Carson JL, et al. Clinical and genetic aspects of primary ciliary dyskinesia/Kartagener syndrome. Genet Med. 2009; 11 (7): 473-487 .
4. Elizur A, Cannon CL, Ferkol TW. Airway inflammation in cystic fibrosis. Chest. 2008; 133 (2): 489-495 .
5. Klein M, Cohen-Cymberknoh M, Armoni S, et al. 18 F-fluorodeoxyglucose- PET/CT imaging of lungs in patients with cystic fibrosis. Chest. 2009; 136 (5): 1220-1228 .
6. Muhlebach MS, Stewart PW, Leigh MW, Noah TL. Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am J Respir Crit Care Med. 1999; 160 (1): 186-191 .
7. Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell. 1993; 73(7): 1251-1254 .
8. de Gracia J, Mata F, Alvarez A, et al. Genotype-phenotype correlation for pulmonary function in cystic fibrosis. Thorax. 2005; 60 (7): 558-563 .
9. Drumm ML, Konstan MW, Schluchter MD, et al Gene Modifier Study Group. Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med. 2005; 353 (14): 1443-1453 .
10. Kerem E, Kerem B. Genotype-phenotype correlations in cystic fibrosis. Pediatr Pulmonol. 1996; 22 (6): 387-395 .
11. Kristidis P, Bozon D, Corey M, et al. Genetic determination of exocrine pancreatic function in cystic fibrosis. Am J Hum Genet. 1992 ; 50 (6): 1178-1184 .
12. Gan KH, Veeze HJ, van den Ouweland AM, et al. A cystic fibrosis mutation associated with mild lung disease. N Engl J Med. 1995 ; 333 (2): 95-99 .
13. Kerem E, Corey M, Kerem BS, et al. The relation between genotype and phenotype in cystic fibrosis - analysis of the most common mutation (delta F508). N Engl J Med. 1990 ; 323 (22): 1517-1522 .
14. Simanovsky N, Cohen-Cymberknoh M, Shoseyov D, et al. Differences in the pattern of structural abnormalities on CT scan in patients with cystic fibrosis and pancreatic suffi- ciency or insufficiency. Chest. 2013 ; 144 (1): 208-214 .
15. Barbato A, Frischer T, Kuehni CE, et al. Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur Respir J. 2009 ; 34 (6): 1264-1276 .
16. Bush A, Payne D, Pike S, Jenkins G, Henke MO, Rubin BK. Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis. Chest. 2006; 129 (1): 118-123 .
17. Santamaria F, Montella S, Tiddens HA, et al. Structural and functional lung disease in primary ciliary dyskinesia. Chest. 2008 ; 134 (2): 351-357 .
18. Rosenstein BJ, Cutting GR; Cystic Fibrosis Foundation Consensus Panel. The diagnosis of cystic fibrosis: a consensus statement. J Pediatr. 1998; 132 (4): 589-595 .
19. Miller MR, Hankinson J, Brusasco V, et al ; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005; 26(2): 319-338 .
20. Wang X, Dockery DW, Wypij D, Fay ME, Ferris BG Jr. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol. 1993; 15 (2): 75-88 .
21. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med. 1999; 159 (1): 179-187 .
22. Brody AS, Kosorok MR, Li Z, et al. Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis. J Thorac Imaging. 2006 ; 21 (1): 14-21 .
23. Davis SD, Fordham LA, Brody AS, et al. Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis. Am J Respir Crit Care Med. 2007; 175(9): 943-950 .
24. Boëlle PY, Viviani L, Busson PF, et al ; French CF Modifier Gene Study Investigators ; European CF Registry Working Group. Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis. Orphanet J Rare Dis. 2012 ; 7 : 64 .
25. Maglione M, Bush A, Montella S, et al. Progression of lung disease in primary ciliary dyskinesia: is spirometry less accurate than CT? Pediatr Pulmonol. 2012 ; 47 (5): 498-504 .
26. Magnin ML, Cros P, Beydon N, et al. Longitudinal lung function and structural changes in children with primary ciliary dyskinesia. Pediatr Pulmonol. 2012 ; 47 (8): 816-825 .
27. Pifferi M, Bush A, Pioggia G, et al. Evaluation of pulmonary disease using static lung volumes in primary ciliary dyskinesia. Thorax. 2012 ; 67 (11): 993-999 .
28. Loeve M, Lequin MH, de Bruijne M, et al. Cystic fibrosis: are volumetric ultra-low-dose expiratory CT scans sufficient for monitoring related lung disease? Radiology. 2009 ; 253 (1): 223-229 .
29. Hamutcu R, Rowland JM, Horn MV, et al. Clinical findings and lung pathology in children with cystic fibrosis. Am J Respir Crit Care Med. 2002 ; 165 (8): 1172-1175 .
30. Strippoli MP, Frischer T, Barbato A, et al; ERS Task Force onPrimary Ciliary Dyskinesia in Children. Management of primary ciliary dyskinesia in European children: recommendations and clinical practice. Eur Respir J. 2012; 39(6): 1482- 1491.
31. McShane D, Davies JC, Wodehouse T, Bush A, Geddes D, Alton EW. Normal nasal mucociliary clearance in CF children: evidence against a CFTR-related defect. Eur Respir J. 2004; 24 (1): 95-100 .
32. Shah SA, Santago P, Rubin BK. Quantification of biopolymer filament structure. Ultramicroscopy. 2005; 104 (3-4): 244-254 .
33. Rubin BK. Mucus structure and properties in cystic fibrosis. Paediatr Respir Rev. 2007; 8 (1): 4-7 .
34. Cohen-Cymberknoh M, Kerem E, Ferkol T, Elizur A. Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications. Thorax. 2013; 68 (12): 1157-1162 .
35. Cohen TS, Prince A. Cystic fibrosis: a mucosal immunodefi- ciency syndrome. Nat Med. 2012; 18 (4): 509-519 .
36. Amirav I, Cohen-Cymberknoh M, Shoseyov D, Kerem E. Primary ciliary dyskinesia: prospects for new therapies, building on the experience in cystic fibrosis. Paediatr Respir Rev. 2009; 10 (2): 58-62 .